The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
The rat brain in stereotaxic coordinates
Palkovits, M. (1983) · Neuropeptides · doi:10.1016/0143-4179(83)90049-5 · Cited by 28,831
Behavioural despair in rats: A new model sensitive to antidepressant treatments
Porsolt, R. D., Anton, G., Blavet, N., & Jalfre, M. (1978) · European Journal of Pharmacology · doi:10.1016/0014-2999(78)90118-8 · Cited by 3,138
Detke, M. J., Rickels, M., & Lucki, I. (1995) · Psychopharmacology · doi:10.1007/bf02245592 · Cited by 1,433
Functional changes of the basal ganglia circuitry in Parkinson's disease
Blandini, F., Nappi, G., Tassorelli, C., & Martignoni, E. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00067-2 · Cited by 582
Papp, M., Willner, P., & Muscat, R. (1991) · Psychopharmacology · doi:10.1007/bf02244188 · Cited by 542
Cognitive dysfunction in Parkinson's disease: the role of frontostriatal circuitry
Owen, A. M. (2004) · The Neuroscientist · doi:10.1177/1073858404266776 · Cited by 496
Poewe, W. H., Rascol, O., Quinn, N., Tolosa, E., Oertel, W. H., Martignoni, E., Rupp, M., & Boroojerdi, B. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70108-4 · Cited by 398
Prevalence, etiology, and treatment of depression in Parkinson’s disease
McDonald, W. M., Richard, I. H., & DeLong, M. R. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00530-4 · Cited by 357
Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson's disease
Tadaiesky, M. T., Dombrowski, P. A., Figueiredo, C. P., Cargnin-Ferreira, E., Da Cunha, C., & Takahashi, R. N. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.08.035 · Cited by 343
Self-citationHigher incidence of depression preceding the onset of Parkinson's disease: A register study
Leentjens, A. F. G., Van den Akker, M., Metsemakers, J. F. M., Lousberg, R., & Verhey, F. R. J. (2003) · Movement Disorders · doi:10.1002/mds.10387 · Cited by 340
Frontal lobe dysfunction in secondary depression
(1994) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.6.4.428 · Cited by 276
Schmitz, C., & Hof, P. R. (2000) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(00)00066-1 · Cited by 272
Björklund, A., Rosenblad, C., Winkler, C., & Kirik, D. (1997) · Neurobiology of Disease · doi:10.1006/nbdi.1997.0151 · Cited by 248
Depression in Parkinson's disease - a review
Lieberman, A. (2006) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2006.00536.x · Cited by 243
Castaño, A., Herrera, A. J., Cano, J., & Machado, A. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00799.x · Cited by 238
The lipopolysaccharide Parkinson’s disease animal model: mechanistic studies and drug discovery
Dutta, G., Zhang, P., & Liu, B. (2008) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.2008.00616.x · Cited by 235
Ferro, M. M., Bellissimo, M. I., Anselmo-Franci, J. A., Angellucci, M. E. M., Canteras, N. S., & Da Cunha, C. (2005) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2005.04.005 · Cited by 225
Risk Factors for Depression in Parkinson Disease
Tandberg, E., Larsen, J. P., Aarsland, D., Laake, K., & Cummings, J. L. (1997) · Archives of Neurology · doi:10.1001/archneur.1997.00550170097020 · Cited by 202
Depression and Parkinson?s disease
Lemke, M., Fuchs, G., Gemende, I., Herting, B., Oehlwein, C., Reichmann, H., Rieke, J., & Volkmann, J. (2004) · Journal of Neurology · doi:10.1007/s00415-004-1606-6 · Cited by 200
Psychiatric aspects of Parkinson?s disease: An Update
Schrag, A. (2004) · Journal of Neurology · doi:10.1007/s00415-004-0483-3 · Cited by 200
Rotenone induces non‐specific central nervous system and systemic toxicity
Lapointe, N., St‐Hilaire, M., Martinoli, M., Blanchet, J., Gould, P., Rouillard, C., & Cicchetti, F. (2004) · The FASEB Journal · doi:10.1096/fj.03-0677fje · Cited by 187
The neuropathological basis for depression in Parkinson's disease
Frisina, P. G., Haroutunian, V. H., & Libow, L. S. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.04.038 · Cited by 173
Winter, C., von Rumohr, A., Mundt, A. P., Petrus, D. S., Klein, J., Lee, T., Morgenstern, R., Kupsch, A. R., & Juckel, G. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.07.002 · Cited by 162
Ling, Z., Zhu, Y., Tong, C. W., Snyder, J. A., Lipton, J. W., & Carvey, P. M. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.01.010 · Cited by 160
Miller, K. M., Okun, M. S., Fernandez, H. H., Jacobson, C. E., Rodriguez, R. L., & Bowers, D. (2007) · Movement Disorders · doi:10.1002/mds.21376 · Cited by 154
Increased striatal dopamine turnover following acute administration of rotenone to mice
Thiffault, C., Langston, J. W., & Monte, D. A. D. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02960-7 · Cited by 149
Evaluation of reward processes in an animal model of depression
Slattery, D. A., Markou, A., & Cryan, J. F. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0630-x · Cited by 138
Saravanan, K. S., Madathil, S. K., & Mohanakumar, K. P. (2005) · Brain Research · doi:10.1016/j.brainres.2005.04.051 · Cited by 135
Cunha, C. D., Gevaerd, M. S., Vital, M. A., Miyoshi, E., Andreatini, R., Silveira, R. D. R., Rn, T., & Canteras, N. S. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00211-x · Cited by 132
Self-citationVuckovic, M. G., Wood, R. I., Holschneider, D. P., Abernathy, A., Togasaki, D. M., Smith, A. J., Petzinger, G. M., & Jakowec, M. W. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.07.015 · Cited by 116
The Role of the Substantia Nigra Pars Compacta in Regulating Sleep Patterns in Rats
Lima, M. M. S., Andersen, M. L., Reksidler, A. B., Vital, M. A. B. F., & Tufik, S. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000513 · Cited by 112
Self-citationDremencov, E., Newman, M. E., Kinor, N., Blatman‐Jan, G., Schindler, C. J., Overstreet, D. H., & Yadid, G. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.09.013 · Cited by 107
Neurotoxins and neurotoxic species implicated in neurodegeneration
Segura‐Aguilar, J., & Kostrzewa, R. M. (2004) · Neurotoxicity Research · doi:10.1007/bf03033456 · Cited by 104
Depression and Parkinson's disease.
Mayeux, R. P., Stern, Y., Williams, J. W., Sano, M., & COTE, L. J. (1984) · PubMed · Cited by 92
Rénéric, J.-P., Bouvard, M. P., & Stinus, L. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00203-6 · Cited by 87
Anhedonia and activity deficits in rats: impact of post-stroke depression
Sh, W., Zhang, Z., Guo, Y., Zhou, H., Teng, G.-J., & Chen, B. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108089814 · Cited by 80
The COX-2 inhibitor parecoxib produces neuroprotective effects in MPTP-lesioned rats
Reksidler, A. B., Lima, M. M. S., Zanata, S. M., Machado, H. B., Cunha, C. D., Andreatini, R., Tufik, S., & Vital, M. A. B. F. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.12.032 · Cited by 79
Self-citationLima, M. D. M. S., Reksidler, A. B., Zanata, S. M., Machado, H. B., Tufik, S., & Vital, M. A. B. F. (2006) · Brain Research · doi:10.1016/j.brainres.2006.05.016 · Cited by 76
Self-citationTreatment of depression in Parkinson's disease
Sawabini, K. A., & Watts, R. L. (2004) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2004.02.002 · Cited by 74
Litteljohn, D., Mangano, E. N., Shukla, N., & Hayley, S. P. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.09.025 · Cited by 73
Kobayashi, T., Hayashi, E., Shimamura, M., Kinoshita, M., & Murphy, N. P. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1070-6 · Cited by 73
Chen, P., Kales, H. C., Weintraub, D. A., Blow, F. C., Jiang, L., & Mellow, A. M. (2007) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988707301866 · Cited by 66
Depression in the patient with Parkinson's disease.
Mayeux, R. P. (1990) · PubMed · Cited by 63
Litteljohn, D., Mangano, E. N., & Hayley, S. P. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06371.x · Cited by 54
Place learning strategy of substantia nigra pars compacta-lesioned rats.
Cunha, C. D., Silva, M. H. C., Wietzikoski, S., Lovato, E. C. W., Ferro, M. M., Kouzmine, I., & Canteras, N. S. (2006) · Behavioral Neuroscience · doi:10.1037/0735-7044.120.6.1279 · Cited by 36
Reksidler, A. B., Lima, M. M. S., Dombrowski, P. A., Andersen, M. L., Zanata, S. M., Andreatini, R., Tufik, S., & Vital, M. A. B. F. (2007) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2007.08.024 · Cited by 35
Self-citationMaintenance treatment with antidepressants in panic disorder.
Noyes, R., & Perry, P. J. (1990) · PubMed · Cited by 23
Distinct Effects of Intranigral L-DOPA Infusion in the MPTP Rat Model of Parkinson’s Disease
Reksidler, A. B., Lima, M. M. S., Dombrowski, P. A., Barnabé, G. F., Andersen, M. L., Tufik, S., & Vital, M. A. B. F. (2009) · Springer eBooks · doi:10.1007/978-3-211-92660-4_21 · Cited by 15
Self-citationTreatment of depression in Parkinson’s disease
Menza, M. A., Dobkin, R. D., & Marín, H. (2006) · Current Psychiatry Reports · doi:10.1007/s11920-006-0029-8 · Cited by 13
Ceravolo, R., Sgadó, P., Frosini, D., & Corsini, G. U. (2006) · Springer eBooks · doi:10.1007/978-3-211-33328-0_15 · Cited by 12
Unger, E. L., Mazzola‐Pomietto, P., Murphy, D. L., & Andrews, A. M. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.037614 · Cited by 11
Крыжановский, Г. Н., Krupina, N. A., & Кучеряну, В. Г. (1995) · PubMed · Cited by 10
Pankova, N. B., Vetrilé, L. A., Basharova, L. A., Krupina, N. A., Khlebnikova, N. N., Rodina, V. I., & Крыжановский, Г. Н. (2003) · Neuroscience and Behavioral Physiology · doi:10.1023/b:neab.0000009207.38914.2b · Cited by 6
Cited by
Kim, S., Kwon, S.-H., Kam, T.-I., Panicker, N., Karuppagounder, S. S., Lee, S., Lee, J. H., Kim, W. R., Kook, M., Foss, C. A., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.05.035 · Cited by 1,397
“The lack of an effect on swimming speed and distance is consistent with the observation that reductions in striatal DA elicited by DA neurotoxins or DA transporter overexpression do not affect swimming speeds and distance (Bernhardt et al., 2018; Da Cunha et al., 2002; Miyoshi et al., 2002; Santiago et al., 2010; Sari…”
BackgroundResultJohnson, M. E., & Bobrovskaya, L. (2015) · NeuroToxicology · doi:10.1016/j.neuro.2014.12.002 · Cited by 332
Depression in neurodegenerative diseases: Common mechanisms and current treatment options
Galts, C. P. C., Bettio, L. E. B., Jewett, D. C., Yang, C. C., Brocardo, P. S., Rodrigues, A. L. S., Thacker, J. S., & Gil-Mohapel, J. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.04.002 · Cited by 269
Kajta, M., & Wójtowicz, A. K. (2013) · Pharmacological Reports · doi:10.1016/s1734-1140(13)71524-x · Cited by 168
de Morais, H., de Souza, C. P., da Silva, L. M., Ferreira, D. M., Werner, M. F., Andreatini, R., da Cunha, J. M., & Zanoveli, J. M. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.10.011 · Cited by 111
Self-citation
Metadata
- Authors
- Santiago, R. M., Barbieiro, J., Lima, M. M. S., Dombrowski, P. A., Andreatini, R., & Vital, M. A. B. F.
- Venue
- Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2010-08
- Volume
- 34
- Issue
- 6
- Pages
- 1104-1114
- ISSN
- 0278-5846 (ISSN-L)
- OpenAlex
- W1993271363
- Cited by
- 252
- References
- 54
- FWCI
- 7.81
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.